This bill aims to enhance access to health care by prohibiting prior authorization requirements for certain medications, specifically those prescribed for antineoplastic cancer treatment, and by ensuring that prior authorization denials cannot be based on the timing of health care services provided. It amends Minnesota Statutes 2024, section 62M.07, to include new provisions that require expedited reviews for medications that have previously been authorized or covered. Additionally, it mandates that prior authorization requests must be accepted for review if submitted within seven days of the health care service being provided, and prohibits denials based on the timing of the request.

Key amendments include the removal of the requirement for prior authorization of antineoplastic cancer treatment medications based on guidelines from the National Comprehensive Cancer Network, replacing it with a standard of nationally and internationally accepted care. The bill also introduces a new subdivision that requires prior authorizations for medications previously authorized for a patient to be processed in a timely manner, ensuring continuity of care. These changes are designed to streamline the authorization process and improve patient access to necessary treatments.

Statutes affected:
Introduction: 62M.07